pharma · Hypertriglyceridemia · Type 2 Diabetes Mellitus · IONS
IONIS PHARMACEUTICALS
IONIS PHARMACEUTICALS INC
IONIS PHARMACEUTICALS patent portfolio — 6 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 2855 Gazelle Ct, Carlsbad, CA 92010, US
- Founded
- 1989
- Employees
- 1,493
- Programs
- 4
- Drugs
- 32
- Patents
- 6
IONIS PHARMACEUTICALS patents
6 pharmaceutical patents indexed for IONIS PHARMACEUTICALS. 0 expire within 24 months.
IONIS PHARMACEUTICALS has 6 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 10683499
Compositions and methods for modulating TTR expression
granted -
US 10294477
Compositions and methods for modulating PKK expression
granted -
US 9670492
Modulation of prekallikrein (PKK) expression
granted -
US 9593333
Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations
granted -
US 9399774
Modulation of transthyretin expression
granted -
US 9315811
Methods for modulating kallikrein (KLKB1) expression
granted
Frequently asked questions
How many patents does IONIS PHARMACEUTICALS have?
6 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do IONIS PHARMACEUTICALS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.